Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Episomal-vector-systems-and-related-methods

 Covalently cross-linked oligonucleotides
OF THE INVENTION In accordance with the objects of this invention novel, covalently cross-linked ...


 Methods of inducing cancer cell death and tumor regression
The present invention provides methods of treating cancer in a patient (e.g., a mammal such as a ...


 Injectable hyaluronic acid derivative with pharmaceuticals/cells
OF THE INVENTION The present invention concerns injectable, biocompatible and biodegradable ...


 Modification of polymer surfaces and molecular immobilization by photoreaction
OF THE INVENTION To obviate disadvantages associated with the modification methods presently ...


 Wound and skin care compositions
What is claimed: 1. A composition comprising a dermatologically acceptable carrier and an effective ...


 Water treatment apparatus
The embodiments of the invention in which an exclusive property or privilege is claimed are defined ...


 Membrane cell
What we claim is: 1. A monopolar filter press electrolytic cell suitable for use in the ...


 Encapsulating biological active substances into erythrocytes
We claim: 1. A process for the encapsulation in human or animal erythrocytes of at least one ...


 Flow chamber and electro-manipulator incorporating same
Accordingly, an object of the present invention is to provide a flow chamber and an electro-...


 Electroblotting technique for transferring specimens from a polyacrylamide electrophoresis or like gel onto a membrane
What is claimed is: 1. An apparatus especially suitable for transferring a biological specimen from ...


 Episomal vector systems and related methods

Details
Inventors: Woo, Savio L. C.; Nordloh, Peter W.; Stenlund, Arne;
Assignee:
Primary Examiner: Chouch; Deborah
Assistant Examiner:
Attorney, Agent or Firm: Lyon & Lyon LLP

An episomal vector sytem and methods for use in gene therapy in humans and animals. The vector contains a papilloma virus origin of replication, a vector maintenance sequence, a first promoter transcriptionally linked to a therapeutic nucleic acid sequence, a second promoter transcriptionally linked to a papilloma virus E1 gene sequence, and a third promoter transcriptionally linked to a papilloma virus E2 gene sequence or an E1/E2 fusion gene. The vector is capable of episomal replication in human or animal cells.

DETAILED DESCRIPTION The present invention provides papilloma virus episomal vector systems and methods for papilloma virus episomal vector replication in a variety of human and animal cells not normally permissive for replication of a particular papilloma virus or for maintenance of a particular papilloma virus sequence.
There are provided episomal vector systems containing papilloma virus E1 and E2 genes and a papilloma virus origin of replication.
These vectors are capable of episomal replication and due to their small size allow for insertion of a therapeutic nucleic acid sequence, which may be efficiently expressed in a human or other animal cell.
In a first aspect the invention features an episomal vector system for gene therapy in humans or animals which contains a polyfunctional nucleic acid sequence from a papilloma virus, the polyfunctional nucleic acid sequence including an origin of replication, a vector maintenance sequence, a first promoter and a unique restriction site for insertion of one or more therapeutic nucleic acid sequences; a first expression cassette containing a papilloma E1 gene sequence and a second promoter to drive transcription of the E1 gene; a second expression cassette containing a papilloma E2 gene sequence and a third promoter to drive transcription of the E2 gene; the first and second expression cassettes cloned into an episomal vector; and the episomal vector system includes one or more episomal vectors, each capable of episomal replication in a human or other animal cell.
In a preferred embodiment this invention features an episomal vector system for gene therapy in humans or animals which contains a polyfunctional nucleic acid sequence from BPV-1 (nucleotides 4780 to 471 from the BPV-1 genome, (e.
g.
, 3636 bp in length)) in a vector, SEQ.
ID.
NO.
1, the polyfunctional nucleic acid sequence including an origin of replication, a vector maintenance sequence, a first promoter and a unique restriction site for insertion of one or more therapeutic nucleic acid sequences; a first expression cassette containing a BPV-1 E1 gene sequence, SEQ



Related patents
  Method for treating Parkinson's disease employing an ATP-sensitive potassium channel blocker
What is claimed is: 1. A method for treating Parkinson's disease, which comprises administering locally to a mammalian species in need of treatment a therapeutically ...
  Method of treatment of parkinson's disease
We claim: 1. A method of treatment of Parkinson's disease in a patient in need of such treatment, which method comprises the step of administering to said patient a ...
  4-aminoethoxy indolone derivatives
What is claimed is: 1. A compound of the formula I: ##STR5## in which: Y is hydrogen, halogen or alkoxy of 1 to 6 carbon atoms; R.sub.1 is hydrogen, alkyl of 1 to 6 ...
  Genetically engineered cells that produce produce L. Dopa
In one aspect, the present invention provides a process of increasing the production of dopamine in a cell, the process comprising transfecting the cell with a first ...
  C. elegans deletion mutants
What is claimed is: 1. A nematode having null mutations in hop-1 and sel-12, said nematode having a combined maternal-effect embryonic lethality and egg laying defective ...
  Feline hepatocyte growth factor
The invention claimed is: 1. An isolated DNA or RNA encoding a protein having an amino acid sequence as shown in SEQ ID NO: 2 or SEQ ID NO: 4. 2. A recombinant vector ...
  ppRB.sup.110 -phosphoprotein the retinoblastoma susceptibility gene product
OF FIGURES FIG. 1 is the chromatogram illustrating the identification of RB proteins by immunoprecipitation with rabbit anti-RB IgG in various cell lines. Human cells ...
  Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
It has now been discovered that tumor formation in a patient can be treated or prevented by administering to the patient an antigen-presenting cell(s) that is loaded ...
  Mutants of the RB and P53 genes
OF THE INVENTION Definitions The term "functional expression of the gene" meant to include the suppression of transcription of the gene, the degradation of the gene ...
  Oncolytic virus therapy
OF THE INVENTION As used herein the term "human cells" means cells isolated from a human, or cultured cells that have been derived from cells isolated from a human and/...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved